当前位置: 首页 > 详情页

IDH mutation-specific radiomic signature in lower-grade gliomas

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Beijing Neurosurgical Institute, Capital Medical University, Beijing, China [2]Neurological Imaging Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China [3]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [4]Brainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China [5]Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [6]Center of Brain Tumor, Beijing Institute for Brain Disorders, Beijing, China [7]China National Clinical Research Center for Neurological Diseases, Beijing, China [8]Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA) [9]National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China
出处:
ISSN:

关键词: isocitrate dehydrogenase lower grade gliomas radiomic signature transcriptome-radiomic analysis prognostic signature

摘要:
Unravelling the heterogeneity is the central challenge for glioma precession oncology. In this study, we extracted quantitative image features from T2-weighted MR images and revealed that the isocitrate dehydrogenase (IDH) wild type and mutant lower grade gliomas (LGGs) differed in their expression of 146 radiomic descriptors. The logistic regression model algorithm further reduced these to 86 features. The classification model could discriminate the two types in both the training and validation sets with area under the curve values of 1.0000 and 0.9932, respectively. The transcriptome-radiomic analysis revealed that these features were associated with the immune response, biological adhesion, and several malignant behaviors, all of which are consistent with biological processes that are differentially expressed in IDH wild type and IDH mutant LGGs. Finally, a prognostic signature showed an ability to stratify IDH mutant LGGs into high and low risk groups with distinctive outcomes. By extracting a large number of radiomic features, we identified an IDH mutation-specific radiomic signature with prognostic implications. This radiomic signature may provide a way to non-invasively discriminate lower-grade gliomas as with or without the IDH mutation.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 2 区 生物
小类 | 2 区 老年医学 3 区 细胞生物学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 细胞生物学 3 区 老年医学
JCR分区:
出版当年[2017]版:
Q1 GERIATRICS & GERONTOLOGY Q2 CELL BIOLOGY
最新[2023]版:
Q2 CELL BIOLOGY Q2 GERIATRICS & GERONTOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Beijing Neurosurgical Institute, Capital Medical University, Beijing, China
共同第一作者:
通讯作者:
通讯机构: [3]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院